Domiodol is a mucolytic and expectorant.[1] It has been marketed in Italy by Maggioni under the trade name Mucolitico Maggioni and sold in syrup, sachet, and tablet form, with a dosage of 60mg three to four times daily in adults. Contraindications include severe renal or hepatic insufficiency.[2]

Domiodol
Clinical data
Trade namesMucolitico Maggioni
ATC code
Identifiers
  • [2-(iodomethyl)-1,3-dioxolan-4-yl]methanol
CAS Number
PubChem CID
ChemSpider
UNII
KEGG
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC5H9IO3
Molar mass244.028 g·mol−1
3D model (JSmol)
  • ICC1OC(CO)CO1
  • InChI=1S/C5H9IO3/c6-1-5-8-3-4(2-7)9-5/h4-5,7H,1-3H2 checkY
  • Key:NEIPZWZQHXCYDV-UHFFFAOYSA-N checkY
  (verify)

References

edit
  1. ^ Kogi K, Konishi K, Saito T (1983). "Pharmacological and toxicological studies on domiodol, a new mucolytic agent and expectorant". Arzneimittel-Forschung. 33 (9): 1281–6. PMID 6685509.
  2. ^ Schlesser JL (1991). Drugs Available Abroad, 1st Edition. Derwent Publications Ltd. p. 70. ISBN 0-8103-7177-4.